GCVTX | VIVIX | GCVTX / VIVIX | |
Total Expense Ratio | 0.67 | 0.04 | 1,675% |
Annual Report Gross Expense Ratio | 0.77 | 0.04 | 1,925% |
Fund Existence | 18 years | 27 years | - |
Gain YTD | 6.587 | 6.730 | 98% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 539M | 195B | 0% |
Annual Yield % from dividends | 1.10 | 2.19 | 50% |
Returns for 1 year | -1.74 | 9.75 | -18% |
Returns for 3 years | 21.22 | 34.32 | 62% |
Returns for 5 years | 34.30 | 74.87 | 46% |
Returns for 10 years | 61.42 | 116.26 | 53% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EMBD | 23.28 | 0.10 | +0.43% |
Global X Emerging Markets Bond ETF | |||
FMED | 24.15 | 0.06 | +0.26% |
Fidelity Disruptive Medicine ETF | |||
AGG | 98.45 | 0.16 | +0.16% |
iShares Core US Aggregate Bond ETF | |||
UBR | 19.03 | N/A | N/A |
ProShares Ultra MSCI Brazil Capped | |||
CGIE | 33.09 | -0.07 | -0.21% |
Capital Group International Equity ETF |